CPRIT approved almost $100 million in grants to advance the fight against cancer in Texas
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
On Jan. 9, 2024, the Institute for Health Metrics and Evaluation (HHMI) reported that despite a gradual decline…
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenメs Health Research, an effort led…
On Nov. 2, 2023, Abbott announced that it had received U.S. Food and Drug Administration (FDA) approval for…
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
On Oct. 7, 2023, California became the first state to ban four chemicals used in well-known candies and…
On Sept. 29, 2023, the U.S. Food and Drug Administration (FDA) granted Invitae de novo marketing authorization for…
On Sept. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that new diagnoses of…
On Sept. 26, 2023, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department…
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
On Sept. 10, 2023, the White House announced $240 million in additional investment through the Advanced Research Projects…
On Sept. 6, 2023, the Markey Cancer Center (MCC) became Kentucky’s first and only National Cancer Institute (NCI)-Designated…
On Aug. 31, 2023, 23andMe, a leading human genetics and biopharmaceutical company, today announced the Company has received…
On Aug. 16, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it took another major…
On Aug. 14, 2023, the National Institute of Health announced that it had released a comprehensive dataset that…
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
On Jun. 26, 2023, Jaguar Health announced that the Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) had joined…
On May 11, 2023, the National Institutes of Health (NIH) announced launching a new program, the Common Fund’s…
On May 3, 2023, National Institutes of Health (NIH) scientists announced that they had uncovered new details on…
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening for…
On Apr. 17, 2023, the U.S. Food and Drug Administration (FDA) approved Gamida Cell’s Omisirge (omidubicel-onlv), a substantially…
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
On Mar. 27, 2023, California Institute for Regenerative Medicine (CIRM) Board approved investing nearly $26 million in 17…